Medical Research and Clinical Trials

Alumis’ Envudeucitinib Shows Promising Phase III Results, Poised to Challenge Competitive Psoriasis Market

• Medical Research and Clinical Trials

Alumis’ Envudeucitinib Shows Promising Phase III Results, Poised to Challenge Competitive Psoriasis Market

Sagoh October 12, 2026

California-based biopharma company Alumis has unveiled compelling data from its pivotal Phase III ONWARD program for envudeucitinib,...

Read More Read more about Alumis’ Envudeucitinib Shows Promising Phase III Results, Poised to Challenge Competitive Psoriasis Market

Unveiling a Cancer’s Deceptive Alliance: OU Researchers Discover How Breast Tumors Recruit Nerves to Fuel Growth

• Medical Research and Clinical Trials

Unveiling a Cancer’s Deceptive Alliance: OU Researchers Discover How Breast Tumors Recruit Nerves to Fuel Growth

Asro October 11, 2026

Oklahoma City, OK – In a significant stride towards understanding and potentially conquering one of the most...

Read More Read more about Unveiling a Cancer’s Deceptive Alliance: OU Researchers Discover How Breast Tumors Recruit Nerves to Fuel Growth

Alumis Poised to Disrupt Psoriasis Market with Promising Envudeucitinib Data Amidst Fierce Competition

• Medical Research and Clinical Trials

Alumis Poised to Disrupt Psoriasis Market with Promising Envudeucitinib Data Amidst Fierce Competition

Jia Lissa October 11, 2026

California-based biopharmaceutical company Alumis has unveiled compelling Phase III clinical trial data for its novel TYK2 inhibitor,...

Read More Read more about Alumis Poised to Disrupt Psoriasis Market with Promising Envudeucitinib Data Amidst Fierce Competition

Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Grow Nerves and Fuel Its Spread

• Medical Research and Clinical Trials

Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Grow Nerves and Fuel Its Spread

Iffa Jayyana October 11, 2026

Oklahoma City, OK – In a groundbreaking discovery that redefines our understanding of cancer progression, new research...

Read More Read more about Unveiling a Master Manipulator: How Aggressive Breast Cancer Hijacks the Immune System to Grow Nerves and Fuel Its Spread

Alumis Bets on Envudeucitinib to Disrupt the Psoriasis Oral Market Amidst Fierce Competition

• Medical Research and Clinical Trials

Alumis Bets on Envudeucitinib to Disrupt the Psoriasis Oral Market Amidst Fierce Competition

Ammar Sabilarrohman October 11, 2026

California-based biopharma company Alumis is poised to launch a significant challenge in the highly competitive oral psoriasis...

Read More Read more about Alumis Bets on Envudeucitinib to Disrupt the Psoriasis Oral Market Amidst Fierce Competition

Groundbreaking Oklahoma Research Uncovers Cancer’s Neural Manipulation, Paving Way for New Treatments

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Uncovers Cancer’s Neural Manipulation, Paving Way for New Treatments

Basiran October 11, 2026

Norman, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...

Read More Read more about Groundbreaking Oklahoma Research Uncovers Cancer’s Neural Manipulation, Paving Way for New Treatments

Alumis Poised to Disrupt Psoriasis Market with Promising Envudeucitinib Data, Facing Fierce Competition

• Medical Research and Clinical Trials

Alumis Poised to Disrupt Psoriasis Market with Promising Envudeucitinib Data, Facing Fierce Competition

Sagoh October 11, 2026

California-based biopharma company Alumis is making a significant push towards the oral psoriasis market with its investigational...

Read More Read more about Alumis Poised to Disrupt Psoriasis Market with Promising Envudeucitinib Data, Facing Fierce Competition

Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

• Medical Research and Clinical Trials

Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

Evan Lee Salim October 10, 2026

NORMAN, OK – In a significant stride for cancer research, scientists at the University of Oklahoma (OU)...

Read More Read more about Unmasking Cancer’s Master Manipulator: OU Research Reveals How Aggressive Breast Tumors Hijack the Immune System to Fuel Growth

Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

• Medical Research and Clinical Trials

Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

Nana Wu October 10, 2026

California-based biopharmaceutical company Alumis is making significant strides towards the launch of its novel oral psoriasis treatment,...

Read More Read more about Alumis Poised to Enter Crowded Psoriasis Market with Promising TYK2 Inhibitor, Envudeucitinib

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth and Resistance

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth and Resistance

Asep Darmawan October 10, 2026

NORMAN, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...

Read More Read more about Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth and Resistance